{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:30:07Z","timestamp":1786987807185,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","earlyhumandevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.earlhumdev.2015.08.003","type":"journal-article","created":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T18:47:38Z","timestamp":1442688458000},"page":"725-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus"],"prefix":"10.1016","volume":"91","author":[{"given":"Brian C.","family":"Gulack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Laughon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reese H.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera N.","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph P.","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Brian Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.CIR.41.2.343","article-title":"The changes in the circulation after birth. Their importance in congenital heart disease","volume":"41","author":"Rudolph","year":"1970","journal-title":"Circulation"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0031-6997(24)01348-6","article-title":"The pharmacology of the ductus arteriosus","volume":"50","author":"Smith","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1152\/physrev.1975.55.1.62","article-title":"Control of the ductus arteriosus","volume":"55","author":"Heymann","year":"1975","journal-title":"Physiol Rev"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/hrt.30.1.4","article-title":"Natural history of persistent ductus arteriosus","volume":"30","author":"Campbell","year":"1968","journal-title":"Br Heart J"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM197609022951003","article-title":"Pharmacologic closure of patent ductus arteriosus in the premature infant","volume":"295","author":"Friedman","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0030","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/jp.2010.175","article-title":"Learning to live with patency of the ductus arteriosus in preterm infants","volume":"31","author":"Benitz","year":"2011","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0090-6980(74)90110-5","article-title":"Studies on closure of the ductus arteriosus. XI. Ductal closure in utero by a prostaglandin synthetase inhibitor","volume":"8","author":"Sharpe","year":"1974","journal-title":"Prostaglandins"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0022-3476(99)70093-4","article-title":"Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus","volume":"135","author":"Pezzati","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.jp.7211429","article-title":"New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure","volume":"26","author":"Attridge","year":"2006","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0055","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/MPG.0b013e3181558591","article-title":"A neonatal mouse model of intestinal perforation: investigating the harmful synergism between glucocorticoids and indomethacin","volume":"45","author":"Gordon","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.jp.7210892","article-title":"Necrotizing enterocolitis among neonates in the United States","volume":"23","author":"Guthrie","year":"2003","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40272-013-0031-7","article-title":"Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure","volume":"15","author":"Pacifici","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.1996.03530310045031","article-title":"Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants","volume":"275","author":"Varvarigou","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0075","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00431-012-1805-6","article-title":"Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus","volume":"171","author":"van der Lugt","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08998280.2007.11928244","article-title":"Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus","volume":"20","author":"Poon","year":"2007","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0085","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1651-2227.2004.tb02702.x","article-title":"Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants","volume":"93","author":"Tatli","year":"2004","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/jp.2010.199","article-title":"Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus","volume":"31","author":"Rao","year":"2011","journal-title":"J Perinatol"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0095","first-page":"166","article-title":"Repeated bowel perforations with Ibuprofen lysine: a case report","volume":"13","author":"Peitz","year":"2008","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0100","series-title":"Lundbeck Inc. announces the voluntary nationwide recall of two lots of NeoProfen (ibuprofen lysine) injection","author":"Young","year":"2010"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00431-004-1596-5","article-title":"A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus","volume":"164","author":"Thomas","year":"2005","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jped.2013.02.006","article-title":"Comparison of oral Ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants","volume":"89","author":"Yang","year":"2013","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0029-1243371","article-title":"Safety and effectiveness of indomethacin versus ibuprofen for treatment of patent ductus arteriosus","volume":"27","author":"Katakam","year":"2010","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-0033-1361933","article-title":"Medication use in the neonatal intensive care unit","volume":"31","author":"Hsieh","year":"2014","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00246-011-9925-8","article-title":"Patent ductus arteriosus in the preterm infant: a survey of clinical practices in French neonatal intensive care units","volume":"32","author":"Brissaud","year":"2011","journal-title":"Pediatr Cardiol"},{"issue":"Suppl. 3","key":"10.1016\/j.earlhumdev.2015.08.003_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14767050903198314","article-title":"Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns","volume":"22","author":"Guimaraes","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0135","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1542\/peds.2009-0913","article-title":"New intrauterine growth curves based on United States data","volume":"125","author":"Olsen","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00220670209598786","article-title":"An introduction to logistic regression analysis and reporting","volume":"96","author":"Peng","year":"2002","journal-title":"J Educ Res"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0145","first-page":"CD003481","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants","volume":"4","author":"Ohlsson","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM200009073431001","article-title":"A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus","volume":"343","author":"Van Overmeire","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1442-200X.2003.01797.x","article-title":"Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants","volume":"45","author":"Su","year":"2003","journal-title":"Pediatr Int"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jss.2014.02.003","article-title":"Patent ductus arteriosus ligation in premature infants in the United States","volume":"190","author":"Tashiro","year":"2014","journal-title":"J Surg Res"},{"key":"10.1016\/j.earlhumdev.2015.08.003_bb0165","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1542\/peds.2005-1528","article-title":"Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000grams or less","volume":"117","author":"Koch","year":"2006","journal-title":"Pediatrics"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037837821500167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037837821500167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T14:34:52Z","timestamp":1748615692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037837821500167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S037837821500167X"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2015.08.003","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2015.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}